2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea.
Autor: | Seo MH; Division of Endocrinology, Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University School of Medicine, Gumi, Korea., Lee WY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim SS; Department of Family Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea., Kang JH; Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea., Kang JH; Department of Family Medicine, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea., Kim KK; Department of Family Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Kim BY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea., Kim YH; Department of Family Medicine, Korea University College of Medicine, Seoul, Korea., Kim WJ; Department of Endocrinology and Metabolism, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea., Kim EM; Department of Dietetics, Kangbuk Samsung Hospital, Seoul, Korea., Kim HS; Department of Sport Science, Seoul National University of Science and Technology, Seoul, Korea., Shin YA; Department of Exercise Prescription and Rehabilitation, Dankook University, Cheonan, Korea., Shin HJ; Department of Pediatrics, National Medical Center, Seoul, Korea., Lee KR; Department of Family Medicine, Dongincheon Gil Hospital, Gachon University of Medicine and Science, Incheon, Korea., Lee KY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea., Lee SY; Department of Family Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea., Lee SK; Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea., Lee JH; Department of Surgery, Ewha Medical Center, Seoul, Korea., Lee CB; Division of Endocrinology and Metabolism, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea., Chung S; Department of Pediatrics, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea., Cho YH; Family Medicine Clinic and Research Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea., Choi KM; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea., Han JS; Research Institute of Human Ecology, Korea University, Seoul, Korea., Yoo SJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of obesity & metabolic syndrome [J Obes Metab Syndr] 2019 Mar; Vol. 28 (1), pp. 40-45. Date of Electronic Publication: 2019 Mar 30. |
DOI: | 10.7570/jomes.2019.28.1.40 |
Abstrakt: | Obesity increases the risks of diabetes, hypertension, and cardiovascular diseases, ultimately contributing to mortality. Korean Society for the Study of Obesity (KSSO) was established to improve the management of obesity through research and education; to that end, the Committee of Clinical Practice Guidelines of KSSO reviews systemic evidence using expert panels to develop clinical guidelines. The clinical practice guidelines for obesity were revised in 2018 using National Health Insurance Service Health checkup data from 2006 to 2015. Following these guidelines, we added a category, class III obesity, which includes individuals with body mass index (BMI) ≥35 kg/m 2 . Agreeing with the International Federation for the Surgery of Obesity and Metabolic Disorders, Asian Pacific Chapter consensus, we determined that bariatric surgery is indicated for Korean patients with BMI ≥35 kg/m 2 and for Korean patients with BMI ≥30 kg/m 2 who have comorbidities. The new guidelines focus on guiding clinicians and patients to manage obesity more effectively. Our recommendations and treatment algorithms can serve as a guide for the evaluation, prevention, and management of overweight and obesity. Competing Interests: CONFLICTS OF INTEREST The authors declare no conflict of interest. |
Databáze: | MEDLINE |
Externí odkaz: |